NASDAQ · BBLG
Bone Biologics Corp
U.S. listed stock · USD15-minute delay
Find an instrument
- AppleAAPL · NASDAQResearch →
- MicrosoftMSFT · NASDAQResearch →
- NvidiaNVDA · NASDAQResearch →
- AmazonAMZN · NASDAQResearch →
- AlphabetGOOGL · NASDAQResearch →
- Meta PlatformsMETA · NASDAQResearch →
- TeslaTSLA · NASDAQResearch →
- JPMorgan ChaseJPM · NYSEResearch →
- ExxonMobilXOM · NYSEResearch →
- WalmartWMT · NASDAQResearch →
- S&P 500 IndexSPX · S&PResearch →
- Nasdaq 100 IndexNDX · NASDAQResearch →
- Dow Jones Industrial AverageDJI · Dow JonesResearch →
- Cboe Volatility IndexVIX · CboeResearch →
- U.S. Dollar IndexDXY · ICEResearch →
- VIX futuresVX1! · Cboe Futures ExchangeResearch →
- DAX futuresFDAX1! · EurexResearch →
- Euro Stoxx 50 futuresFESX1! · EurexResearch →
- E-mini S&P 500 futuresES1! · CMEResearch →
- E-mini Nasdaq 100 futuresNQ1! · CMEResearch →
- E-mini Dow futuresYM1! · CBOTResearch →
- E-mini Russell 2000 futuresRTY1! · CMEResearch →
- WTI crude oil futuresCL1! · NYMEXResearch →
- Natural gas futuresNG1! · NYMEXResearch →
- Gold futuresGC1! · COMEXResearch →
- Silver futuresSI1! · COMEXResearch →
- Euro FX futures6E1! · CMEResearch →
- Japanese yen futures6J1! · CMEResearch →
- BitcoinBTCUSD · BitstampResearch →
- EtherETHUSD · BitstampResearch →
- Research Any U.S. stock or ETF tickerResearch →
No matching names. Type a U.S. stock ticker (for example MU) to research it.
Loading price chart…
Price chart by TradingView
15-minute delay. Chart times and available timeframes are controlled by the provider.
Earnings
Earnings calendarThe next earnings date for BBLG has not been announced yet.
| Fiscal quarter end | Consensus EPS forecast | High | Low | Estimates |
|---|---|---|---|---|
| Dec 2026 | $-0.18 | $-0.18 | $-0.18 | 1 |
Source: Nasdaq, based on Zacks Investment Research consensus estimates. Dates marked as expected may change.
News
RTTNews · Quiver Quantitative · Fintel · InvestorPlace- RTTNews · Aug 12, 9:45 AM EDTBone Biologics Extends RhNELL-1 Shelf Life To 32 Months, Strengthening Study Readiness; Stock Down(RTTNews) – Bone Biologics Corporation (BBLG) announced that the validated shelf life of its rhNELL-1 protein has been extended to 32 months, marking a key milestone in manufacturing flexibility and pivotal-study preparation.
- RTTNews · Jul 8, 1:41 AM EDTBone Biologics Prices Up To $9 Mln Private Placement Of Shares And Warrants;Stock Up(RTTNews) – Bone Biologics Corporation (BBLG), an orthobiologic product developer for spine fusion markets, announced that it has entered into a definitive agreement with a single healthcare-focused institutional investor. The agreement provides for the issuance and sale of 2.1
- RTTNews · Jun 27, 12:44 PM EDTBone Biologics Prices $5 Mln Public Offering With Warrants At $4 Per Share(RTTNews) – Bone Biologics Corporation (BBLG), a developer of orthobiologic products for spine fusion, has priced a public offering of 1,250,000 shares of common stock, Series D warrants, and Series E short-term warrants, each exercisable for one common share at $4.00 per share.
- RTTNews · Jun 27, 7:52 AM EDTWhy Bone Biologics Is Rising In Pre-market?(RTTNews) – Bone Biologics (BBLG) announced the filing of a patent application with the United States Patent and Trademark Office for its NELL-1 protein. The patent application is directed to compositions of rhNELL-1 polypeptide and uses thereof for treating bone conditions.
- RTTNews · Jun 6, 10:14 AM EDTBone Biologics To Implement 1-for-6 Reverse Stock Split Effective June 10, 2025(RTTNews) – Bone Biologics Corporation (BBLG) has announced a 1-for-6 reverse stock split of its common stock, which will take effect at 12:01 a.m. ET on Tuesday, June 10, 2025.
- Quiver Quantitative · May 12, 6:50 PM EDTBONE BIOLOGICS Earnings Results: $BBLG Reports Quarterly EarningsBONE BIOLOGICS ($BBLG) posted quarterly earnings results on Monday, May 12th. The company reported earnings of -$0.32 per share, beating estimates of -$0.49 by $0.17. The company also reported revenue of $0, equaling estimates of $0 by $0.
- RTTNews · Mar 4, 10:26 AM ESTBone Biologics Announces Pricing Of $2 Mln Public Offering(RTTNews) – Monday, Bone Biologics Corp. (BBLG) announced the pricing of its public offering of 781,251 shares of common stock and warrants to purchase up to the same number of shares, for $2.56 per share.
- RTTNews · Dec 18, 8:28 AM ESTBone Biologics Authorised For 1-for-8 Reverse Stock Split(RTTNews) – Bone Biologics Corp. (BBLG) Monday announced a planned reverse stock split of its shares of common stock at a ratio of 1-for-8, effective 12.01 am ET December 20.
- Fintel · Jul 6, 11:14 AM EDTBone Biologics (BBLG) Price Target Increased by 738.89% to 38.51The average one-year price target for Bone Biologics (OTC:BBLG) has been revised to 38.50 / share. This is an increase of 738.89% from the prior estimate of 4.59 dated June 1, 2023. The price target is an average of many targets provided by analysts. The lates
- RTTNews · Jan 11, 7:36 AM ESTPre-market Movers: ONE, TSRI, BBLG, AHI, ACCD…(RTTNews) – The following are some of the stocks making big moves in Tuesday's pre-market trading (as of 07.20 A.M. ET).
- InvestorPlace · Jan 10, 3:50 PM ESTBBLG Stock Alert: 7 Things to Know as Bone Biologics Skyrockets TodayInvestorPlace – Stock Market News, Stock Advice & Trading Tips
- RTTNews · Jan 10, 7:33 AM ESTPre-market Movers: AIZ, APR, RVPH, BBLG, MOLN…(RTTNews) – The following are some of the stocks making big moves in Monday's pre-market trading (as of 07.20 A.M. ET).
Stories from Nasdaq.com, including Zacks, The Motley Fool and Barchart. They open on the publisher’s site; AiFs Market does not edit or endorse them.
Company profile
Loading company profile…
Company profile by TradingView
Financials
Loading fundamental data…
Fundamental data by TradingView
More headlines
More stories for Bone Biologics Corp from TradingView. Coverage varies.
Loading related news…
Related news by TradingView
Quotes, charts, company information and headlines are supplied by TradingView. Data may be delayed or unavailable. This page is for market research and does not provide investment advice.